Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial - Sartor, O; Coleman, R; Nilsson, S; Heinrich, D; Helle, SI; O’Sullivan, JM (Lancet Oncol, 2014)
et al.